RAPT Therapeutics
RAPT
RAPT was delisted on the 2nd of March, 2026.
99 hedge funds and large institutions have $1.02B invested in RAPT Therapeutics in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 34 reducing their positions, and 21 closing their positions.
2,497% more call options, than puts
Call options by funds: $12.9M | Put options by funds: $495K
25% more capital invested
Capital invested by funds: $818M → $1.02B (+$202M)
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
0.59% more ownership
Funds ownership: 11.19% → 11.78% (+0.59%)
7% less funds holding
Funds holding: 106 → 99 (-7)
18% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 34
19% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$37M |
| 2 |
State Street
Boston,
Massachusetts
|
+$30M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$9.92M |
| 4 |
Morgan Stanley
New York
|
+$7.89M |
| 5 |
O
OrbiMed
New York
|
+$7.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$15.6M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$8.94M |
| 3 |
EC
Euclidean Capital
New York
|
-$6.76M |
| 4 |
ROTUOC
Regents of the University of California
Oakland,
California
|
-$5.51M |
| 5 |
SG Americas Securities
New York
|
-$5.22M |
RAPT Hedge Fund Activity: Q4 2021 in Review
99 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q4 2021, worth a combined $1.02B — up 25% from $818M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of RAPT and 17 opened new positions — a net loss of 4 holders — while 34 trimmed existing stakes and 28 added.
The largest buyer was Fidelity Investments, adding an estimated $37M. The largest seller was Millennium Management, cutting an estimated $15.6M.
- 99 institutional investors held RAPT Therapeutics (RAPT) as of Q4 2021, down from 106 in Q3 2021.
- Funds reported $1.02B of RAPT Therapeutics stock for Q4 2021, up 25% quarter-over-quarter.
- 17 funds opened new RAPT Therapeutics positions in Q4 2021 and 21 closed out, a net change of -4 holders.
- The largest RAPT Therapeutics buyer in Q4 2021 was Fidelity Investments, an estimated $37M added.
- The largest RAPT Therapeutics seller in Q4 2021 was Millennium Management, an estimated $15.6M sold.
Based on aggregated 13F filings for Q4 2021.